These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29573959)

  • 1. Severe life-threatening asthma precipitated by a topical nonsteroidal anti-inflammatory drug.
    Foong NZE; Yii ACA; Hsu AAL
    Ann Allergy Asthma Immunol; 2018 May; 120(5):535-536. PubMed ID: 29573959
    [No Abstract]   [Full Text] [Related]  

  • 2. Single-breath counting for the assessment of bronchospastic patients in the ED.
    Ushkow BS; Bartfield JM; Reicho PR; Raccio-Robak N
    Am J Emerg Med; 1998 Jan; 16(1):100-1. PubMed ID: 9451330
    [No Abstract]   [Full Text] [Related]  

  • 3. Current options in the treatment of acute bronchospasm.
    Berger WE
    Postgrad Med; 2005 Dec; 118(6 Suppl Acute):18-26. PubMed ID: 19667712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective cyclooxygenase-2 inhibitor cross-reactivity in aspirin-exacerbated respiratory disease.
    Umemoto J; Tsurikisawa N; Nogi S; Iwata K; Oshikata C; Tatsuno S; Tanimoto H; Sekiya K; Tsuburai T; Mitomi H; Akiyama K
    Allergy Asthma Proc; 2011; 32(3):259-61. PubMed ID: 21703104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance of daily low-dose aspirin does not preclude aspirin-exacerbated respiratory disease.
    Lee-Sarwar K; Johns C; Laidlaw TM; Cahill KN
    J Allergy Clin Immunol Pract; 2015; 3(3):449-51. PubMed ID: 25634222
    [No Abstract]   [Full Text] [Related]  

  • 6. Omalizumab: a potential new therapeutic approach for aspirin-exacerbated respiratory disease.
    Bobolea I; Barranco P; Fiandor A; Cabañas R; Quirce S
    J Investig Allergol Clin Immunol; 2010; 20(5):448-9. PubMed ID: 20945617
    [No Abstract]   [Full Text] [Related]  

  • 7. On the use of selected bronchodilators in the asthmatic and non-asthmatic patient.
    Chrow L
    AANA J; 1978 Aug; 46(4):389-96. PubMed ID: 716823
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin Sensitivity in Patients with Moderate to Severe Asthma.
    Arshi S; Eslami N; Nabavi M; Bemanian MH; Fallahpour M; Shokri S; Ahmadian J; Molatefi R; Darabi K; Sedighi GR; Moinfar Z; Darougar S
    Iran J Allergy Asthma Immunol; 2020 Aug; 19(4):447-451. PubMed ID: 33463111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acute bronchospasm in elderly patients.
    Berger WE
    Postgrad Med; 2005 Dec; 118(6 Suppl Acute):34-7; discussion 38. PubMed ID: 19667714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of isoetharine and albuterol: report of changes in pulmonary functions over 1 hour.
    Yates T; Dubin B; Bell-Jesion C
    J Am Osteopath Assoc; 1982 Apr; 81(8):546-8. PubMed ID: 7042663
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperreactive airway.
    Hirshman CA
    Int Anesthesiol Clin; 1986; 24(1):21-9. PubMed ID: 3512452
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
    Tan JHY; Hsu AAL
    Respir Med; 2016 Sep; 118():1-3. PubMed ID: 27578463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reversible bronchial spasm syndrome in the very old].
    Pfitzenmeyer P; Lauwerier C; Camus A
    Presse Med; 1998 May; 27(18):878-83. PubMed ID: 9767879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
    Mastalerz L; Celejewska-Wójcik N; Wójcik K; Gielicz A; Januszek R; Cholewa A; Stręk P; Sanak M
    Allergy; 2014 Nov; 69(11):1550-9. PubMed ID: 25123806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchodilator therapy (second of two parts).
    Webb-Johnson DC; Andrews JL
    N Engl J Med; 1977 Oct; 297(14):758-64. PubMed ID: 408685
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukotriene modifiers to prevent aspirin-provoked respiratory reactions in asthmatics.
    Volkman JA; Pontikes PJ
    Ann Pharmacother; 2002 Sep; 36(9):1457-61. PubMed ID: 12196067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of a new Bronchodilator agent in the prevention and control of bronchial spasm induced by surface anesthesin].
    Ancetti A; Caputo G
    Minerva Anestesiol; 1977 Jan; 43(1):15-26. PubMed ID: 846652
    [No Abstract]   [Full Text] [Related]  

  • 18. Blocking aspirin-induced bronchospasm.
    Lang DM
    Ann Allergy Asthma Immunol; 2005 Oct; 95(4):307-8. PubMed ID: 16279556
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic rhinosinusitis and aspirin intolerance].
    Leunig A; Braunschweig F; Havel M; Markmann S; Kramer M; Menz G
    MMW Fortschr Med; 2009 Jan; 151(5):44-5. PubMed ID: 19391414
    [No Abstract]   [Full Text] [Related]  

  • 20. Control of bronchospasm in patients with chronic obstructive pulmonary diseases.
    Snider GL
    Chest; 1978 Jun; 73(6 Suppl):927-35. PubMed ID: 98294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.